Scientists have found the strongest evidence to date that a condition known as Barrett’s oesophagus is the starting point for all cases of oesophageal adenocarcinoma – the most common type of oesophageal cancer in the developed world – even when telltale signs of this pre-cancerous stage are no longer visible.
For Brain Tumour Awareness Month 2026, we spoke to Dr Inês Prata Machado about her work at the CRUK Cambridge Centre where interdisciplinary teams translate scientific discoveries into real-world benefits for patients.
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Shades of Survival, a powerful documentary film featuring Cambridge researchers, highlights global inequities in breast cancer care for Black women. It will have its world premiere at the Cambridge Film Festival later this month.
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over 15,000 women a year, say scientists at the University of Cambridge.
Four Cambridge biomedical and health researchers are among those announced today as newly-elected Fellows of the Academy of Medical Sciences.
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.
How AI supercomputer, Dawn, is being used to tackle some of the most pressing issues facing humanity.
Dr Mireia Crispin is an Assistant Professor in the Department of Oncology at the University of Cambridge and leads a research group focusing on the development of multi-omic data integration models to understand how tumours evolve and respond to treatment.
Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.
© 2026 University of Cambridge